Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls

Fertility and Sterility

Volumn 74, Issue 3, 2000, Pages 564-572

  Wu, Xiao Ke ^a,b,c   Sallinen, Kirsimarja ^a   Anttila, Leena ^a   Mäkinen, Marjaana ^b   Luo, Cheng ^b   Pöllänen, Pasi ^a,b   Erkkola, Risto ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c JINLING HOSPITAL   (China)

Author keywords

Gestational diabetes mellitus; Insulin resistance; Insulin receptor substrates; Ovary; Polycystic ovary syndrome

Indexed keywords

INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2;

ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOCHEMISTRY; INSULIN RESISTANCE; OVARY CYCLE; OVARY INSUFFICIENCY; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADULT; CELLS, CULTURED; DIABETES, GESTATIONAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR WEIGHT; OLIGOMENORRHEA; OVARY; PHOSPHOPROTEINS; POLYCYSTIC OVARY SYNDROME; PREGNANCY;

EID: 0033835617     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(00)00688-9     Document Type: Article

References (31)

1. Roy S.K., Terada D.M. Activities of glucose metabolic enzymes in human preantral follicles in vitro modulation by follicle-stimulating hormone, luteinizing hormone, epidermal growth factor, insulin-like growth factor 1, and transforming growth factor beta 1 . Biol Reprod. 60:1999;763-768.
2. Kol S., Ben-Shlomo I., Ruutiainen K., Ando M., Davies-Hill T.M., Rohan R.M., et al. The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process. J Clin Invest. 99:1997;2274-2283.
3. Dunaif A., Xia J., Book C.B., Schenker E., Tang Z. Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome. J Clin Invest. 96:1995;801-810.
4. Nestler J.E., Jakubowicz D.J., de Vargas A.F., Brik C., Quintero N., Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 83:1998;2001-2005.
5. Lin Y., Fridstrom M., Hillensjo T. Insulin stimulation of lactate accumulation in isolated human granulosa-luteal cells a comparison between normal and polycystic ovaries . Hum Reprod. 12:1997;2469-2472.
6. Gjonnaess H. The course and outcome of pregnancy after ovarian electrocautery in women with polycystic ovarian syndrome the influence of body-weight . Br J Obstet Gynaecol. 96:1989;714-719.
7. Legro R.S., Kunselman A.R., Dodson W.C., Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome a prospective, controlled study in 254 affected women . J Clin Endocrinol Metab. 84:1999;165-169.
8. Holte J., Gennarelli G., Wide L., Lithell H., Berne C. High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus. J Clin Endocrinol Metab. 83:1998;1143-1150.
9. White M.F. The IRS-signaling system a network of docking proteins that mediate insulin and cytokine action . Recent Prog Horm Res. 53:1998;119-138.
10. Tamemoto H., Kadowaki T., Tobe K., Yagi T., Sakura H., Hayakawa T., et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372:1994;182-186.
11. Withers D.J., Gutierrez J.S., Towery H., Burks D.J., Ren J.M., Previs S., et al. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:1998;900-904.
12. Saltiel A.R. Diverse signaling pathways in the cellular actions of insulin. Am J Physiol. 270:1996;E375-E385.
13. Classification and diagnosis of diabetes mellitus and other categories of glucose tolerance. Diabetes. 28:1979;1039-1057.
14. Wu J., Zhang L., Liu P. A new source of human oocytes preliminary report on the identification and maturation of human preantral follicles from follicular aspirates . Hum Reprod. 13:1998;2561-2563.
15. Samoto T., Maruo T., Matsuo H., Katayama K., Barnea E.R., Mochizuki M. Altered expression of insulin and insulin-like growth factor-l receptors in follicular and stromal compartments of polycystic ovaries. Endocr J. 40:1993;413-424.
16. Nobels F., Dewailly D. Puberty and polycystic ovarian syndrome the insulin/insulin-like growth factor l hypothesis . Fertil Steril. 58:1992;655-666.
17. Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab. 50:1980;113-116.
18. Robinson S., Kiddy D., Gelding S.V., Willis D., Niththyananthan R., Bush A., et al. The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. Clin Endocrinol (Oxf). 39:1993;351-355.
19. Filicori M., Flamigni C., Cognigni G., Dellai P., Michelacci L., Arnone R. Increased insulin secretion in patients with multifollicular and polycystic ovaries and its impact on ovulation induction. Fertil Steril. 62:1994;279-285.
20. Nestler J.E., Jakubowicz D.J., Evans W.S., Pasquali R. Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med. 338:1998;1876-1880.
21. Amiel S.A., Caprio S., Sherwin R.S., Plewe G., Haymond M.W., Tamborlane W.V. Insulin resistance of puberty a defect restricted to peripheral glucose metabolism . J Clin Endocrinol Metab. 72:1991;277-282.
22. Rondinone C.M., Wang L.M., Lonnroth P., Wesslau C., Pierce J.H., Smith U. Insulin receptor substrate (IRS)-1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 94:1997;4171-4175.
23. Jiang Z.Y., Lin Y.W., Clemont A., Feener E.P., Hein K.D., Igarashi M., et al. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest. 104:1999;447-457.
24. Palumbo A., Yeh J. Apoptosis as a basic mechanism in the ovarian cycle follicular atresia and luteal regression . J Soc Gynecol Investig. 2:1995;565-573.
25. Homburg R., Amsterdam A. Polycystic ovary syndrome - loss of the apoptotic mechanism in the ovarian follicles? J Endocrinol Invest. 21:1998;552-557.
26. Peruzzi F., Prisco M., Dews M., Salomoni P., Grassilli E., Romano G., et al. Multiple signaling pathways of the insulin like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol. 19:1999;7203-7215.
27. Catalano P.M., Tyzbir E.D., Roman N.M., Amini S.B., Sims E.A. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 165:1991;1667-1672.
28. Kjos S.L., Peters R.K., Xiang A., Henry O.A., Montoro M., Buchanan T.A. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes. 44:1995;586-591.
29. Friedman J.E., Ishizuka T., Shao J., Huston L., Highman T., Catalano P. Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes. 48:1999;1807-1814.
30. Book C.B., Dunaif A. Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 84:1999;3110-3116.
31. Werner H., Shen-Orr Z., Stannard B., Burguera B., Roberts C.T. Jr, Leroith D. Experimental diabetes increases insulin like growth factor 1 and 2 receptor concentration and gene expression in kidney. Diabetes. 39:1990;1490-1497.